The DOI matches its Crossref record.
Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT
Open accessAbstract
Between 1978 and 1996 more than 7500 lymphoma transplants have been reported to the European Bone Marrow Transplantation (EBMT) Lymphoma Registry. This has been examined to establish the incidence of secondary leukaemia and myelodysplasia and to relate this to possible prognostic factors. 131 centres representing 4998 patients responded to a questionnaire. This identified 66 patients with post transplant myelodysplastic syndrome (MDS)/acute myeloid leukaemia (AML). The actuarial risk for MDS/AML at 5 years post‐transplant (±95% CI) was 4.6% (3.1–6.8) for Hodgkin's disease and 3.0% (2.0–4.3) for non‐Hodgkin's lymphoma. Multivariate analysis for all patients demonstrated an effect of age at transplant, radiotherapy at conditioning, number of transplants and interval between diagnosis and transplant as risk factors. For patients with NHL, grade of histology was important (low grade > intermediate or high‐grade); for Hodgkin's disease, female sex was identified as a risk factor. These findings suggest that the incidence of MDS/AML may not be greater following an autograft than after conventional chemotherapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Haioun, C., Lepage, E., Gisselbrecht, C., Salles, G., Coiffier, B., Brice, P., Bosly, A., Morel, P., Nouvel, C., Tilly, H., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.16.3025 · Cited by 421
Baker, K. S., DeFor, T. E., Burns, L. J., Ramsay, N. K. C., Neglia, J. P., & Robison, L. L. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.108 · Cited by 317
Aetiology, genetics and prevention of secondary neoplasms in adult cancer survivors
Travis, L. B., Wahnefried, W. D., Allan, J. M., Wood, M. E., & Ng, A. K. (2013) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2013.41 · Cited by 264
Metafuni, E., Chiusolo, P., Laurenti, L., Sorà, F., Giammarco, S., Bacigalupo, A., Leone, G., & Sica, S. (2018) · Mediterranean Journal of Hematology and Infectious Diseases · doi:10.4084/mjhid.2018.005 · Cited by 14
Metadata
- Authors
- Milligan, D. W., Ruiz de Elvira, M. C., Kolb, H., Goldstone, A. H., Meloni, G., Rohatiner, A. Z., Colombat, P., & Schmitz, N.
- Venue
- British Journal of Haematology
- Publisher
- Wiley
- Published
- 1999-09
- Volume
- 106
- Issue
- 4
- Pages
- 1020-1026
- ISSN
- 0007-1048 (ISSN-L)
- 1365-2141
- OpenAlex
- W2003999130
- Cited by
- 167
- References
- 0
- FWCI
- 9.95
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. https://app.cochat.ai/papers/10.1046/j.1365-2141.1999.01627.x
- The paper
- Milligan, D. W., Ruiz de Elvira, M. C., Kolb, H., Goldstone, A. H., Meloni, G., Rohatiner, A. Z., Colombat, P., & Schmitz, N. (1999). Secondary leukaemia and myelodysplasia after autografting for lymphoma: results from the EBMT. British Journal of Haematology. https://doi.org/10.1046/j.1365-2141.1999.01627.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.